/[corp_html]/news/38.html
This is repository of my old source code which isn't updated any more. Go to git.rot13.org for current projects!
ViewVC logotype

Contents of /news/38.html

Parent Directory Parent Directory | Revision Log Revision Log


Revision 1.1.1.1 - (show annotations) (vendor branch)
Mon Feb 12 08:29:30 2001 UTC (18 years, 4 months ago) by dpavlin
Branch: MAIN, dbp
CVS Tags: alpha, HEAD
Changes since 1.1: +0 -0 lines
File MIME type: text/html
alpha

1 <p align="center"><b>A New Mandate for the Members of PLIVA's Management Board
2 </b></p>
3 <p>As the mandates of PLIVA's Management Board members are expiring, the company's
4 Supervisory Board appointed the Management Board members for a new five-year
5 period. The decision was made at the Supervisory Board meeting held on 07 September
6 2000 and will become effective as of 08 December 2000. </p>
7 <p>In accordance with PLIVA's corporate governance principles, to sustain efficient
8 business operations the members of the Management Board are also chief officers
9 in charge of certain areas of operations. In the new mandate the Management
10 Board will include Mr. Zeljko Covic, M.Sc., President of the Management Board
11 and Chief Executive Officer, Mr. Dubravko Mak, Vice President and Chief Operating
12 Officer, Dr. Radan Spaventi, Vice President and Chief Scientific Officer, and
13 Mr. Zeljko Peric, Vice President and Chief Financial Officer.</p>
14 <p> The mandate of Ms. Erika Kaspar, M.Sc., expires as of 08 December 2000, after
15 which she will continue to carry out business operations in the area of Corporate
16 Affairs and Communications.</p>
17 <p> Commenting the decision, Mr. Zeljko Covic, President of PLIVA's Management
18 Board and CEO, said: "My colleagues and I are honoured that we have been given
19 the opportunity to continue realising our long-term strategy. Our new mandates
20 will be in line with the transformation of PLIVA from a local company into a
21 global pharmaceutical company. My team of associates and I, together with all
22 PLIVA employees, will strive to make PLIVA a distinguished European pharmaceutical
23 company, the foundations of which are set in our core values such as innovation,
24 quality, business ethics and dedication of each and every employee, to the benefit
25 of our shareholders. I would like to use this opportunity to thank the previous
26 members of the Management Board and all our associates who have made PLIVA's
27 success possible over the years."</p>
28 <p> For further information, please contact:</p>
29 <p> Dijana Kobas <br>
30 Director, Corporate Communications<br>
31 Tel: 00 385 1 61 20 852<br>
32 Fax: 00 385 1 61 60 358<br>
33 E-mail: <a href="mailto:dijana.kobas@pliva.hr">Dijana.Kobas@pliva.hr </a></p>

  ViewVC Help
Powered by ViewVC 1.1.26